[1]
“Evaluation of Adverse Effects of Sodium Stibogluconate in the Treatment of Visceral Leishmaniasis”, Khwaja Yunus Ali Medical College Journal, vol. 3, no. 1, pp. 239–243, Feb. 2013, doi: 10.3329/kyamcj.v3i1.13659.